Does Dr. SHADI AYYOUB have financial conflicts of interest?

Dr. SHADI AYYOUB (MD) has received a total of $248 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $248 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SHADI AYYOUB?

According to CMS Open Payments data, Dr. SHADI AYYOUB received funding from SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US ($55), LA JOLLA PHARMACEUTICAL COMPANY ($41), and PFIZER ($37).

Does Dr. SHADI AYYOUB receive research grants or speaking fees?

Dr. SHADI AYYOUB has received $248 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SHADI AYYOUB

MDReal-Time Hydrated

Specialty: Hospitalist

Practice Location: ST AUGUSTINE, FL 32086

NPI Number: 1477674232

LIFETIME INDUSTRY VALUE

$248

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AYYOUB is a verified Hospitalist practitioner based in ST AUGUSTINE, FL.

Between 2021 and 2025, Dr. AYYOUB had an overall industry promotional and research financial footprint of $248 as recorded in the federal CMS Open Payments database.

$248 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AYYOUB's primary funding source is SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, which accounts for $55 (representing 22.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US

Rank 1

$55

22.3%

LA JOLLA PHARMACEUTICAL COMPANY

Rank 2

$41

16.4%

PFIZER

Rank 3

$37

14.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.